Aptamer Group PLC (AIM:APTA)
London · Delayed Price · Currency is GBP · Price in GBX 0.6150
-0.0100 (-1.60%)
Apr 15, 2026, 4:10 PM GMT
Aptamer Group Market Cap
Aptamer Group has a market cap or net worth of 18.29 million as of April 15, 2026. Its market cap has increased by 246.67% in one year.
Market Cap
18.29M
Enterprise Value
17.10M
Revenue
1.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.62
Market Cap Chart
Since December 22, 2021, Aptamer Group's market cap has decreased from 97.55M to 18.29M, a decrease of -81.25%. That is a compound annual growth rate of -32.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 14, 2026 | 18.29M | -36.90% |
| Dec 31, 2025 | 28.99M | 308.04% |
| Dec 31, 2024 | 7.11M | 32.20% |
| Dec 29, 2023 | 5.37M | -84.73% |
| Dec 30, 2022 | 35.20M | -62.04% |
| Dec 31, 2021 | 92.73M | -4.95% |
| Dec 22, 2021 | 97.55M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ImmuPharma | 30.67M |
| Poolbeg Pharma | 29.61M |
| SkinBioTherapeutics | 25.27M |
| Arecor Therapeutics | 24.92M |
| Sareum Holdings | 23.47M |
| Fusion Antibodies | 18.13M |
| Genflow Biosciences | 11.52M |
| Cizzle Biotechnology Holdings | 9.32M |